All AbMole products are for research use only, cannot be used for human consumption.
Bromocriptine, an ergoline derivative, is a dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease (PD), hyperprolactinaemia, neuroleptic malignant syndrome, and type 2 diabetes.
Neural Regen Res. 2024 May;19(5):1142-1149.
Bromocriptine protects perilesional spinal cord neurons from lipotoxicity after spinal cord injury
Bromocriptine Mesylate purchased from AbMole
| Molecular Weight | 750.7 |
| Formula | C32H40BrN5O5.CH4O3S |
| CAS Number | 22260-51-1 |
| Solubility (25°C) | DMSO ≥ 50 mg/mL |
| Storage | -20°C, protect from light, sealed |
[3] Christy M Weiland, et al. Bromocriptine mesylate (Cycloset) for type 2 diabetes mellitus
| Related Dopamine Receptor Products |
|---|
| Apomorphine hydrochloride hemihydrate
Apomorphine hydrochloride hemihydrate is a dopamine D2 agonist. |
| SV 156
SV 156 is a potent and selective D2 dopamine receptor antagonist, with a Ki of 2.5 nM for hD2. SV 156 has approximately 40-fold binding selectivity for D2 dopamine receptors compared to the D3 receptor subtype. |
| Cyclo(glycyl-L-leucyl)
Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminergic supersensitivity. |
| Onzigolide
Onzigolide (BIM-23A760), a chimeric dopamine-somatostatin compound, shows potent agonist activity at both DA type 2 (D2R) and SST type 2 (SSTR2) receptors. |
| CVL-871
CVL-871 is a partial agonist at dopamine D1/5 receptors and may be used in dementia-related studies. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
